New FIT stool test shows promise
Share on PinterestResearchers say a new stool test could reduce the number of people who need to undergo a colonoscopy to screen for colorectal cancer.Charles Gürn/Getty Images Colorectal cancer is the third most commonly diagnosed cancer in men and women in the United States, excluding skin cancer.. Colorectal cancer screening has reduced cancer incidence since […]
KRAS-targeted vaccine shows efficacy against pancreatic and colon cancer
Credit: Westend61/Getty Images Colorectal and pancreatic cancers (the second and third leading causes of cancer death, respectively) often have mutations in the KRAS protein. Now, a new vaccine targeting KRAS could be used as an off-the-shelf treatment for patients with pancreatic or colorectal cancer, according to a study co-led by researchers at Memorial Sloan Kettering […]
BMS’ Opdivo regimen shows promise in colorectal cancer clinical trials
BMS’ Opdivo plus Yervoy significantly improved progression-free survival in patients with MSI-H/dMMR metastatic colorectal cancer. Credit: Bristol-Myers Squibb Company. bristol myers squib (BMS) is a Phase III CheckMate-8HW clinical trial combining Opdivo (nivolumab) and Yervoy (ipilimumab) as a first-line treatment option for microsatellite-high instability (MSI-H) or mismatch repair deficiency (dMMR). reported promising data. Metastatic colorectal […]
Research Shows Increased Risk of Cancer in Relatives of People with Leukemia
Relatives of patients with myelodysplastic tumors (MDS), acute myeloid leukemia (AML), or acute lymphoblastic leukemia (ALL) are at increased risk of cancer, according to a study published in the February issue of the journal It was revealed. cancer epidemiology. Nikolaj Juul Nitschke and colleagues at Copenhagen University Hospital in Denmark used linked data from the […]
New study shows better biomarkers for MSI mCRC
This transcript has been edited for clarity. I’m David Kerr, Professor of Cancer Medicine at the University of Oxford.Today I would like to talk about the following A really great paper published earlier this year Oncology annual report By an excellent French group. As you know, we have always had a strong interest in precision […]
Motixafortide shows efficacy as primary treatment for pancreatic cancer in phase 2 trial
Pancreas image | Image credit: © Лилия Захарчук – Stock.adobe.com Motixafortide, a CXC4 inhibitor, when combined with the PD-1 inhibitor cemiplimab and the standard of care (SoC) chemotherapy treatment gemcitabine and nab-paclitaxel (MCGN) Phase 2 Data from the CheMo4METPANC trial (NCT04543071) showed some positive results against (mPDAC). This data, presented as an abstract as part […]
New drug combination shows efficacy against early colorectal cancer
Pathologist Erica Hisson (left) and oncologist Pashtun Kashi (right) are two of the scientists involved in a new study demonstrating the effectiveness of a new immunotherapy for colorectal cancer. Weill Cornell Medicine When given before surgery, a combination immunotherapy developed by biotechnology company Agenus destroyed more than 80% of the tumor before it could be […]